v3.21.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 16,950,710 $ 14,223,917
Accounts receivable, net 978,761 1,080,656
Accounts receivable, related party net 267,300
Prepaid expenses and other current assets 688,820 415,915
Inventories, net 2,020,549 2,420,179
Advances on contracts 753,197 414,202
Total current assets 21,659,337 18,554,869
Furniture, fixtures and equipment, net 27,074 30,729
Intangibles, net 317,896 329,249
Right of use assets 612,576 632,453
Other assets 24,150 24,150
Total assets 22,641,033 19,571,450
Current liabilities:    
Accounts payable 694,044 482,972
Accounts payable, related party 184,360 385,138
Accrued expenses and other payables 1,178,907 824,454
Accrued expenses, related party 382,627 586,734
Current portion of finance leases liabilities 7,977 7,796
Current portion of operating lease right-of-use liabilities 73,596 72,031
Deferred profit, related party 241,288 242,589
Note payable 276,180 276,180
Total current liabilities 3,038,979 2,877,894
Finance lease liabilities 26,544 28,607
Operating lease liabilities 538,421 557,981
Total liabilities 3,603,944 3,464,482
Commitments and contingencies
Stockholders’ equity    
Common stock, par value $.001; authorized 85,000,000 shares; 66,591,883 shares issued and 66,558,550 shares outstanding as of March 31, 2021; 64,171,435 shares issued and 64,138,102 shares outstanding as of December 31, 2020; 66,591 64,171
Additional paid in capital 121,848,254 117,934,696
Accumulated deficit (101,858,826) (100,885,957)
Treasury stock, at cost, 33,333 shares (911,516) (911,516)
Total Milestone Scientific Inc. stockholders' equity 19,144,503 16,201,394
Noncontrolling interest (107,414) (94,426)
Total stockholders’ equity 19,037,089 16,106,968
Total liabilities and stockholders’ equity $ 22,641,033 $ 19,571,450

Source